Default company panoramic image
8d4b3bd3 e0e2 45f2 98a8 d39744090e83

Immunome Inc

Immunome has developed a technology that rapidly and productively discovers new cancer therapies by harnessing the immune system.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded February 2008
  • Employees 4
  • Website immunomeinc.com

Company Summary

Immunome is a biotechnology company that uses its proprietary technology and processes to discover and develop new cancer therapies using a totally new approach. We leverage our technology and investment through industry partnerships that provide non-dilutive capital while we develop maximum value and the product potential that leads to exit opportunities with these same partners.

Team

  • Default avatar
    Jane Holmes Hollingsworth
    Executive Chair

    Jane is Managing Partner of Militia Hill Ventures and co-founder and former CEO of NuPathe, a public company focused on diseases of the central nervous system. Jane is also founder and former EVP of Auxilium, another public pharmaceutical company. Prior to that, Jane was VP & General Counsel of IBAH, a public multinational CRO. Before joining IBAH, Jane practiced law at Montgomery, McCracken, Walker & Rhoads in Philadelphia.

  • Default avatar
    Scott Dessain
    Chief Scientific Officer

    Dr. Dessain is an Associate Professor at the Lankenau Institute for Medical Research and Co-founder and Chief Scientific Officer of Immunome. He received his MD and PhD from Yale and post-graduate training at Brigham and Women's Hospital and Dana Farber Cancer Care. His post-doctoral training was with Dr. Robert Weinberg at the Whitehead Institute in Cambridge. Dr. Dessain was also an instructor at Massachusetts General Hospital and on the facul

  • Default avatar
    Joan Lau
    COO

    Joan Lau is Managing Partner of Militia Hill Ventures and COO of Immunome Inc. She has served as president and CEO with several venture-backed biotechnology companies including Azelon and Locus Pharmaceuticals. Prior to Locus, Dr. Lau worked at Merck & Co, in leadership roles within R&D drug development and business development.

  • Default avatar
    Joel Sussman
    CFO

    Joel Sussman is a financial management consultant who serves in the capacity of CFO for early-stage companies. His present and former clients include numerous venture capital-backed life sciences companies – including Adolor, BioRexis, Cardiokine, Gentara, Neotropix and Valeo Medical. He also served as CFO and/or Treasurer of public and private technology and healthcare companies.

Advisors

  • Default avatar
    Kate Shay, Duane Morris
    Lawyer
    Unconfirmed
    Default avatar
    Gold Gocial Gerstein LLC
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    BioAdvance
    Unconfirmed
    Default avatar
    MidAtlantic Venture Group
    Unconfirmed
    Default avatar
    Wistar Morris
    Unconfirmed